11 results match your criteria: "Clinical Investigation Center 1414[Affiliation]"

A biological pharmacology network to secure the risk of drug-drug interaction with nirmatrelvir/ritonavir.

Therapie

July 2024

Université de Rennes, CHU de Rennes, Inserm, EHESP, Institut de recherche en santé, environnement et travail (Irset), UMR S 1085, 35000 Rennes, France; Inserm, Clinical Investigation Center 1414, 35000 Rennes, France; FHU SUPORT, 35000 Rennes, France.

Nirmatrelvir/ritonavir is a protease inhibitor antiviral drug indicated in the treatment of severe acute respiratory syndrome coronavirus-2 infections in high-risk patients for a severe disease. Unfortunately, ritonavir, used to boost nirmatrelvir pharmacokinetics, can also inhibit or induce the metabolism of other co-administered drugs substrates. This may lead to a subsequent risk of adverse drug reaction and lack of efficacy.

View Article and Find Full Text PDF

Drug-resistant juvenile myoclonic epilepsy: A literature review.

Rev Neurol (Paris)

April 2024

Epilepsy Unit, Reference Center for Rare Epilepsies, Neurology Department, Clinical Investigation Center 1414, Rennes University Hospital, Rennes, France; Signal and Image Processing Laboratory (LTSI), INSERM, Rennes University, Rennes, France. Electronic address:

The ILAE's Task Force on Nosology and Definitions revised in 2022 its definition of juvenile myoclonic epilepsy (JME), the most common idiopathic generalized epilepsy disorder, but this definition may well change again in the future. Although good drug response could almost be a diagnostic criterion for JME, drug resistance (DR) is observed in up to a third of patients. It is important to distinguish this from pseudoresistance, which is often linked to psychosocial problems or psychiatric comorbidities.

View Article and Find Full Text PDF

Therapeutic targeting of the transforming growth factor beta (TGFβ) pathway in cancer represents a clinical challenge since TGFβ exhibits either tumor suppressive or tumor promoting properties, depending on the tumor stage. Thus, treatment with galunisertib, a small molecule inhibitor of TGFβ receptor type 1, demonstrated clinical benefits only in subsets of patients. Due to the functional duality of TGFβ in cancer, one can hypothesize that inhibiting this pathway could result in beneficial or adverse effects depending on tumor subtypes.

View Article and Find Full Text PDF

Letter by Omarjee Regarding Article, "Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial".

Circulation

October 2022

NuMeCan (Nutrition, Metabolism and Cancer) Insitute. EXPRES (Exogenous and endogenous stress, plasticity of responses and diseases) Team. Mixed Research Unit 1241 INSERM (National Institute of Health and Medical Research), Rennes University Hospital, F-35033, Rennes, France. Vascular Medicine Department, Clinical Investigation Center 1414, Rennes University Hospital, F-35033, Rennes, France. Vascular Medicine Unit, Redon Hospital, F-35600, Redon, France. ODYSSEY Research For A Better Life Non-Profit Organization, F-97410, Saint-Pierre, La Reunion, France.

View Article and Find Full Text PDF

Objective: The aim of the study was to evaluate the impact of the use of a reinforced stapler (RS) during distal pancreatectomy (DP) on postoperative outcomes.

Background: DP remains associated with significant postoperative morbidity owing to pancreatic fistula (PF). To date, there is no consensus on the management of the pancreatic stump.

View Article and Find Full Text PDF

Detection of Morphological Abnormalities in Schizophrenia: An Important Step to Identify Associated Genetic Disorders or Etiologic Subtypes.

Int J Mol Sci

August 2021

Pôle Hospitalo-Universitaire de Psychiatrie de l'Enfant et de l'Adolescent (PHUPEA), Centre Hospitalier Guillaume Régnier, University of Rennes 1, 35000 Rennes, France.

Article Synopsis
  • Current research indicates that both genetic and environmental factors significantly increase the risk of developing schizophrenia, particularly during critical developmental stages like prenatal development and adolescence.
  • The article highlights various epidemiological studies, such as family and twin studies, that support the genetic basis of schizophrenia, along with a review of genetic disorders linked to the condition.
  • The findings emphasize the importance of early detection through clinical genetic assessments to identify neurodevelopmental abnormalities and improve prevention, diagnosis, and treatment strategies for those at high risk for schizophrenia.
View Article and Find Full Text PDF

Predictive medicine in multiple sclerosis: A systematic review.

Mult Scler Relat Disord

May 2020

SPHERE (methodS in Patient-centered outcomes & HEalth ResEarch) U1246, INSERM, Nantes University, Tours University, Nantes, France; Nantes University Hospital, Nantes, France. Electronic address:

Background: One of the main challenges in multiple sclerosis (MS) is to predict disease progression based on patient characteristics and therapeutic strategies. We therefore performed a systematic review to critically appraise the composite tools available for this purpose.

Methods: We performed electronic database searches in MEDLINE, EMBASE, Web of Science and the Cochrane Library.

View Article and Find Full Text PDF

Large granular lymphocyte (LGL) leukemia has been recognized by the World Health Organization classifications amongst mature T-cell and natural killer (NK) cell neoplasms. There are 3 categories: chronic T-cell leukemia and NK-cell lymphocytosis, which are similarly indolent diseases characterized by cytopenias and autoimmune conditions as opposed to aggressive NK-cell LGL leukemia. Clonal LGL expansion arise from chronic antigenic stimulation, which promotes dysregulation of apoptosis, mainly due to constitutive activation of survival pathways including Jak/Stat, MapK, phosphatidylinositol 3-kinase-Akt, Ras-Raf-1, MEK1/extracellular signal-regulated kinase, sphingolipid, and nuclear factor-κB.

View Article and Find Full Text PDF